Live feed
Filing
SC 13D
SC 13D0000897069-20-000396·Processa Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Processa Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 74275C106
Event date: 2020-10-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,991,168
- Percent of class
- 14.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000897069-20-000396
- Form type
- SC 13D
- Filer
- Processa Pharmaceuticals, Inc.
- CIK
- CIK 1533743
- Filed
- Oct 13, 2020
- Reporting period
- Oct 02, 2020
- Description
- Schedule 13D beneficial ownership